Treatment of advanced stages head and neck cancers, including nasopharyngeal carcinoma.
Treatment of high-grade astrocytoma as monotherapy, in children refractory to oncospecific treatment.
Treatment of glioblastoma multiforme in combination with radiation therapy in adults.
Treatment of patients with inoperable esophageal malignancy with epithelial origin.